SlideShare a Scribd company logo
NEONATAL
HYPERBILIRUBINEMA
Akshaya O S
Roll no:14
Neonatal hyperbilirubinemia
Definition:
Jaundice is the yellow color
of the skin and sclerae caused
by deposits of bilirubin.
When is visible?
Adult sclera > 2mg/dl
Newborn skin > 5 mg/dl
Incidence of
neonatal
jaundice
Incidence in Term :Occurs in 60%
Preterm : 80% of preterm neonates
Jaundice is the most common
condition that requires medical
attention in newborns
Mainly unconjugated or indirect
hyperbilrubinemia is seen in
newborn
Mechanisms of Neonatal Jaundice
Types of jaundice
PATHOLOGICAL
JAUNDICE
● Appears within 24 hours of age
● Increase of bilirubin >5 mg/dl/day
● Serum bilirubin > 15 mg/dl
● Jaundice days Jaundice persisting after 14
days.
● Stool clay/white colored and urine
staining yellow staining clothes
● Direct bilirubin > 2 mg/dl
PHYSIOLOGICAL
JAUNDICE
● Appears after 24 hours
● Total bilirubin rises by less than 5 mg/dl
per day
● Maximum intensity by 4th-5th day in term
&7th day in preter
● Serum level less than 15 mg/dl Clinically
not detectable after 14 days
CAUSES
Of
Neonatal
jaundice
In 1st 24 Hours:
1-Hemolytic disorders (G6PD-Spherocytosis)
2-TORCH (congenital infection)
2nd day- 3rd week:
1-Physiological (disappear after the 1stweek)
2-Breast milk
3-Sepsis
4-Polycythemia
5-Cephalhematoma
6-Criggler-Najjar Syndrome
7-Hemolytic disorders
Appearance or Persistence after 3rd week:
1-Breast milk
2-Hypothyrodism
3-Pyloric stenosis
4-Cholestasis
Breastfeeding Jaundice
● Jaundice appears between 24 and 72 hours of age, peaks by 5-15
days of life and disappears by the third week of life.
● Mild clinical jaundice in the third week of life, which may
persist into the 2nd to 3rd month of life in a few babies.
● This increased frequency of breastfeeding jaundice is due to
inadequate breastfeeding.
● Ensuring optimum breastfeeding would help decrease this kind of
jaundice.
Breast Milk Jaundice
● 2-4% of exclusively breastfed term babies have jaundice.( in excess of 10 mg/dL
beyond 3rd-4th weeks of life.)
● These babies should be investigated for prolonged jaundice if this is unconjugated
(not staining nappies); and other causes for prolongation have been ruled out.
● Etiology:- Pregnanediol and free fatty acids in breast milk interfere with the
conjugation,increased enterohepatic circulation
● Mothers should be advised to continue breastfeeding at frequent intervals and
TSB levels usually decline over a period of time.
● Some babies may require phototherapy.
HISTORY-POINTS TO BE ASKED
Examination
Clinical Estimation
● Described by Kramer
● Dermal staining of bilirubin may be used as a clinical guide to the level of jaundice.
Dermal staining in newborn progresses in a cephalocaudal
direction. The newborn should be examined in good daylight. The
skin of forehead, chest, abdomen, thighs, legs, palms and soles
should be blanched with digital pressure and the underlying color
of skin and subcutaneous tissue should be noted.
● Yellow staining of palms and soles is a danger sign and requires urgent serum bilirubin
estimation and further management.
Non invasively,bilirubin levels can be assessed by transcutaneous bilirubinometer
Serum levels of total bilirubin are approximately
4-6 mg/dL (zone 1),
6-8 mg/dL (zone 2)
8-12 mg/dL (zone 3)
12-14 mg/dL (zone 4)
15 mg/dL (zone 5)
Yellow staining of palms and
soles is a DANGER SIGN
TRANSCUTANEOUS BILIRUBINOMETER
Complications
● Lethargy
● Poor sucking
● Poor or absent Moro's
● Retrocollis-opisthotonos
● Convulsions
Clinical Features of Acute Encephalopathy
Clinical Features of Chronic Encephalopathy
● Athetosis
● Upward gaze
● Sensorineural hearing loss
● Dental enamel hypoplasia
MANAGEMENT
INVESTIGATIONS
FIRST LINE
• Total serum bilirubin
and its fractions
• Blood groups of
mother and baby
• Peripheral smear
SECOND LINE
• Hematocrit
• G6PD levels
• Sepsis screen
• TFT
• Urine for reducing substances
• Specific enzyme
1.Phototherapy
PRINCIPLE
● Phototherapy is an effective and safe method for reducing indirect bilirubin levels,
particularly when initiated before serum bilirubin increases to levels associated with
kernicterus.
● In term infants - indirect bilirubin levels between 16 and 18 mg/dL.
● premature infants - bilirubin is at lower levels, to prevent bilirubin from reaching the
high concentrations necessitating exchange transfusion.
● Blue lights and white lights are effective
PRINCIPLES
1.Configurational isomerization :- Z isomers of bilirubin are converted to E
isomers.The reaction is instantaneous upon exposure to light but reversible as bilirubin
reaches the bile duct.
2.Structural Isomerization:- Irrevrsible reaction where bilirubin is converted into
lumirubin.The reaction is directly proportional to dose of phototherapy.responsible for
the main decline in TSB
TYPES OF PHOTOTHERAPY LIGHTS
● Compact flouroscent lamps
● Halogen bulbs
● High intensity LED
● Fibreoptic light source
With easy availability and low cost in
Inida,CFL phototherapy is being most
commonly used device.Often CFL devices
Side effects of phototherapy
● Increased insensible water loss
● Loose stools
● Skin rash
● Bronze baby syndrome
● Hypertherma
● May result in hypocalcemia
2.Exchange transfusion
● Exchange transfusion usually is reserved for infants with dangerously high indirect
bilirubin level who are at risk for kernicterus.
● The exchangeable level of indirect bilirubin for other infants may be estimated by
calculating 10% of birth weight in grams
STEPS
● Normal blood volume in neonates – 80 ml/kg in a full term baby.
● Therefore 160 ml/kg of blood is required for exchange transfusion (after blood
grouping and cross matching ).
● Procedure has to be performed under complete aseptic precautions.
● Baby placed in supine position.
● Perform Umbilical vein catheterization and confirm position by radiograph.
● If isovolumetric double exchange is to be done umbilical artery catheter is to be
inserted.
● Have the unit of blood ready.Attach the bag of blood to the tubings and confirm
orientation of 3 way stopcocks.
● Establish the volume of each aliquot
● Exchange transfusion is done by the push pull technique through the umbilical
vein
● After exchange transfusion,phototherapy is continued and bilirubin lebels are
measured every 12 hours.
● Complications – metabolic acidosis, electrolyte abnormalities, hypoglycemia,
hypocalcemia, thrombocytopenia, volume overload, arrythmia, infection,
GVHD and death
3.Intravenous immune globulin
● IVIG in infants with Rh or ABO isoimmunization can
significantly reduce the need for exchange transfusions.
● Now IVIG has replaced exchange transfusion as the
second-line treatment in infants with isoimmune
jaundice.
● IVIG 0.5-1 gm/kg/dose IV repeat 12 hourly
4.Phenobarbital (Luminal)
Hyperbilirubinemia: 3-8 mg/kg/d PO/IV initially; may
increase up to 12 mg/kg/d Not to exceed IV administration
rate of 1 mg/kg/min or 30 mg/min for infants.It increases
the hepatic glucuronly transferase activity – criggler najar
syndrome,gilbert syndrome
Neonatal hyperbilirubinemia.pptx

More Related Content

Similar to Neonatal hyperbilirubinemia.pptx

Neonatal jaundice
Neonatal jaundiceNeonatal jaundice
Neonatal jaundice
Binand Moirangthem
 
Approach to neonatal jaundice
Approach to neonatal jaundiceApproach to neonatal jaundice
Approach to neonatal jaundice
Chethan Channegowda
 
Jaundice
JaundiceJaundice
Jaundice
Eric General
 
Hyperbilirubinemia
HyperbilirubinemiaHyperbilirubinemia
Hyperbilirubinemia
Shini Cherian
 
NNJ.pptx
NNJ.pptxNNJ.pptx
NNJ.pptx
AmninaSaif
 
Neonatal Jaundice.pptx
Neonatal Jaundice.pptxNeonatal Jaundice.pptx
Neonatal Jaundice.pptx
Yusra Khan
 
NNHB by dr ankur puri
NNHB by dr ankur puriNNHB by dr ankur puri
NNHB by dr ankur puri
Ankur Puri
 
Newborn hyperbilirubinemia
Newborn hyperbilirubinemiaNewborn hyperbilirubinemia
Newborn hyperbilirubinemia
Musa Abusabha
 
case presentation on neonatal jaundice
case presentation on neonatal jaundicecase presentation on neonatal jaundice
case presentation on neonatal jaundice
Dr.Hashim Syed Ali (Dr.Foster)
 
APPROACH TO NEONATAL JAUNDICE imp t.pptx
APPROACH TO NEONATAL JAUNDICE imp t.pptxAPPROACH TO NEONATAL JAUNDICE imp t.pptx
APPROACH TO NEONATAL JAUNDICE imp t.pptx
Rajender Singh Lodhi
 
Jaundice neonatal
Jaundice neonatal  Jaundice neonatal
Jaundice neonatal H.M.Bubshait
 
Neonatal jaundice
Neonatal jaundiceNeonatal jaundice
Neonatal jaundice
Shambhavi Sharma
 
RJ-JAUNDICE.pptx
RJ-JAUNDICE.pptxRJ-JAUNDICE.pptx
RJ-JAUNDICE.pptx
Rashi773374
 
Neonatal jaundice
Neonatal jaundice Neonatal jaundice
Neonatal jaundice
Manori Gamage
 
Neonatal jaundice presentation
Neonatal jaundice presentationNeonatal jaundice presentation
Neonatal jaundice presentation
SHRUTISHARMA569
 
jaundice-mnb.pptx
jaundice-mnb.pptxjaundice-mnb.pptx
jaundice-mnb.pptx
Mudreka3
 
Neonatal icterus.pptx
Neonatal icterus.pptxNeonatal icterus.pptx
Neonatal icterus.pptx
L Ngahneilam
 
pathological jaundice
pathological jaundicepathological jaundice
pathological jaundice
TheShraddha
 
NEONATAL JAUNDICE 8/12/2015(HOWRAH)
NEONATAL JAUNDICE 8/12/2015(HOWRAH)NEONATAL JAUNDICE 8/12/2015(HOWRAH)
NEONATAL JAUNDICE 8/12/2015(HOWRAH)
Sudarshan M
 

Similar to Neonatal hyperbilirubinemia.pptx (20)

Neonatal jaundice
Neonatal jaundiceNeonatal jaundice
Neonatal jaundice
 
Approach to neonatal jaundice
Approach to neonatal jaundiceApproach to neonatal jaundice
Approach to neonatal jaundice
 
Jaundice
JaundiceJaundice
Jaundice
 
Hyperbilirubinemia
HyperbilirubinemiaHyperbilirubinemia
Hyperbilirubinemia
 
NNJ.pptx
NNJ.pptxNNJ.pptx
NNJ.pptx
 
Neonatal Jaundice.pptx
Neonatal Jaundice.pptxNeonatal Jaundice.pptx
Neonatal Jaundice.pptx
 
NNHB by dr ankur puri
NNHB by dr ankur puriNNHB by dr ankur puri
NNHB by dr ankur puri
 
Newborn hyperbilirubinemia
Newborn hyperbilirubinemiaNewborn hyperbilirubinemia
Newborn hyperbilirubinemia
 
neonatal jaundice
neonatal jaundiceneonatal jaundice
neonatal jaundice
 
case presentation on neonatal jaundice
case presentation on neonatal jaundicecase presentation on neonatal jaundice
case presentation on neonatal jaundice
 
APPROACH TO NEONATAL JAUNDICE imp t.pptx
APPROACH TO NEONATAL JAUNDICE imp t.pptxAPPROACH TO NEONATAL JAUNDICE imp t.pptx
APPROACH TO NEONATAL JAUNDICE imp t.pptx
 
Jaundice neonatal
Jaundice neonatal  Jaundice neonatal
Jaundice neonatal
 
Neonatal jaundice
Neonatal jaundiceNeonatal jaundice
Neonatal jaundice
 
RJ-JAUNDICE.pptx
RJ-JAUNDICE.pptxRJ-JAUNDICE.pptx
RJ-JAUNDICE.pptx
 
Neonatal jaundice
Neonatal jaundice Neonatal jaundice
Neonatal jaundice
 
Neonatal jaundice presentation
Neonatal jaundice presentationNeonatal jaundice presentation
Neonatal jaundice presentation
 
jaundice-mnb.pptx
jaundice-mnb.pptxjaundice-mnb.pptx
jaundice-mnb.pptx
 
Neonatal icterus.pptx
Neonatal icterus.pptxNeonatal icterus.pptx
Neonatal icterus.pptx
 
pathological jaundice
pathological jaundicepathological jaundice
pathological jaundice
 
NEONATAL JAUNDICE 8/12/2015(HOWRAH)
NEONATAL JAUNDICE 8/12/2015(HOWRAH)NEONATAL JAUNDICE 8/12/2015(HOWRAH)
NEONATAL JAUNDICE 8/12/2015(HOWRAH)
 

More from ssusere8f40d

Nutritional health programmes in India.pptx
Nutritional health programmes in India.pptxNutritional health programmes in India.pptx
Nutritional health programmes in India.pptx
ssusere8f40d
 
PREMATURITY (1).pptx
PREMATURITY (1).pptxPREMATURITY (1).pptx
PREMATURITY (1).pptx
ssusere8f40d
 
Approach to Anemia in children.pptx
Approach to Anemia in children.pptxApproach to Anemia in children.pptx
Approach to Anemia in children.pptx
ssusere8f40d
 
adrenal insufficiency addison Cushing (1).pdf
adrenal insufficiency addison Cushing (1).pdfadrenal insufficiency addison Cushing (1).pdf
adrenal insufficiency addison Cushing (1).pdf
ssusere8f40d
 
Hereditary spherocytosis.pptx
Hereditary spherocytosis.pptxHereditary spherocytosis.pptx
Hereditary spherocytosis.pptx
ssusere8f40d
 
aplastic anemia.pptx
aplastic anemia.pptxaplastic anemia.pptx
aplastic anemia.pptx
ssusere8f40d
 
ACUTE FLACCID PARALYSIS.pptx
ACUTE FLACCID PARALYSIS.pptxACUTE FLACCID PARALYSIS.pptx
ACUTE FLACCID PARALYSIS.pptx
ssusere8f40d
 
Pediatric instruments.pptx
Pediatric instruments.pptxPediatric instruments.pptx
Pediatric instruments.pptx
ssusere8f40d
 
breast feeding week.pptx
breast feeding week.pptxbreast feeding week.pptx
breast feeding week.pptx
ssusere8f40d
 
high risk newborns followup NEW.pptx
high risk newborns followup NEW.pptxhigh risk newborns followup NEW.pptx
high risk newborns followup NEW.pptx
ssusere8f40d
 
ADEM.pdf
ADEM.pdfADEM.pdf
ADEM.pdf
ssusere8f40d
 
acute hepatitis.pdf
acute hepatitis.pdfacute hepatitis.pdf
acute hepatitis.pdf
ssusere8f40d
 
acid base balance.pdf
acid base balance.pdfacid base balance.pdf
acid base balance.pdf
ssusere8f40d
 

More from ssusere8f40d (13)

Nutritional health programmes in India.pptx
Nutritional health programmes in India.pptxNutritional health programmes in India.pptx
Nutritional health programmes in India.pptx
 
PREMATURITY (1).pptx
PREMATURITY (1).pptxPREMATURITY (1).pptx
PREMATURITY (1).pptx
 
Approach to Anemia in children.pptx
Approach to Anemia in children.pptxApproach to Anemia in children.pptx
Approach to Anemia in children.pptx
 
adrenal insufficiency addison Cushing (1).pdf
adrenal insufficiency addison Cushing (1).pdfadrenal insufficiency addison Cushing (1).pdf
adrenal insufficiency addison Cushing (1).pdf
 
Hereditary spherocytosis.pptx
Hereditary spherocytosis.pptxHereditary spherocytosis.pptx
Hereditary spherocytosis.pptx
 
aplastic anemia.pptx
aplastic anemia.pptxaplastic anemia.pptx
aplastic anemia.pptx
 
ACUTE FLACCID PARALYSIS.pptx
ACUTE FLACCID PARALYSIS.pptxACUTE FLACCID PARALYSIS.pptx
ACUTE FLACCID PARALYSIS.pptx
 
Pediatric instruments.pptx
Pediatric instruments.pptxPediatric instruments.pptx
Pediatric instruments.pptx
 
breast feeding week.pptx
breast feeding week.pptxbreast feeding week.pptx
breast feeding week.pptx
 
high risk newborns followup NEW.pptx
high risk newborns followup NEW.pptxhigh risk newborns followup NEW.pptx
high risk newborns followup NEW.pptx
 
ADEM.pdf
ADEM.pdfADEM.pdf
ADEM.pdf
 
acute hepatitis.pdf
acute hepatitis.pdfacute hepatitis.pdf
acute hepatitis.pdf
 
acid base balance.pdf
acid base balance.pdfacid base balance.pdf
acid base balance.pdf
 

Recently uploaded

ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 

Recently uploaded (20)

ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 

Neonatal hyperbilirubinemia.pptx

  • 2. Neonatal hyperbilirubinemia Definition: Jaundice is the yellow color of the skin and sclerae caused by deposits of bilirubin. When is visible? Adult sclera > 2mg/dl Newborn skin > 5 mg/dl
  • 3. Incidence of neonatal jaundice Incidence in Term :Occurs in 60% Preterm : 80% of preterm neonates Jaundice is the most common condition that requires medical attention in newborns Mainly unconjugated or indirect hyperbilrubinemia is seen in newborn
  • 4.
  • 6. Types of jaundice PATHOLOGICAL JAUNDICE ● Appears within 24 hours of age ● Increase of bilirubin >5 mg/dl/day ● Serum bilirubin > 15 mg/dl ● Jaundice days Jaundice persisting after 14 days. ● Stool clay/white colored and urine staining yellow staining clothes ● Direct bilirubin > 2 mg/dl PHYSIOLOGICAL JAUNDICE ● Appears after 24 hours ● Total bilirubin rises by less than 5 mg/dl per day ● Maximum intensity by 4th-5th day in term &7th day in preter ● Serum level less than 15 mg/dl Clinically not detectable after 14 days
  • 7. CAUSES Of Neonatal jaundice In 1st 24 Hours: 1-Hemolytic disorders (G6PD-Spherocytosis) 2-TORCH (congenital infection) 2nd day- 3rd week: 1-Physiological (disappear after the 1stweek) 2-Breast milk 3-Sepsis 4-Polycythemia 5-Cephalhematoma 6-Criggler-Najjar Syndrome 7-Hemolytic disorders Appearance or Persistence after 3rd week: 1-Breast milk 2-Hypothyrodism 3-Pyloric stenosis 4-Cholestasis
  • 8.
  • 9. Breastfeeding Jaundice ● Jaundice appears between 24 and 72 hours of age, peaks by 5-15 days of life and disappears by the third week of life. ● Mild clinical jaundice in the third week of life, which may persist into the 2nd to 3rd month of life in a few babies. ● This increased frequency of breastfeeding jaundice is due to inadequate breastfeeding. ● Ensuring optimum breastfeeding would help decrease this kind of jaundice.
  • 10. Breast Milk Jaundice ● 2-4% of exclusively breastfed term babies have jaundice.( in excess of 10 mg/dL beyond 3rd-4th weeks of life.) ● These babies should be investigated for prolonged jaundice if this is unconjugated (not staining nappies); and other causes for prolongation have been ruled out. ● Etiology:- Pregnanediol and free fatty acids in breast milk interfere with the conjugation,increased enterohepatic circulation ● Mothers should be advised to continue breastfeeding at frequent intervals and TSB levels usually decline over a period of time. ● Some babies may require phototherapy.
  • 13. Clinical Estimation ● Described by Kramer ● Dermal staining of bilirubin may be used as a clinical guide to the level of jaundice. Dermal staining in newborn progresses in a cephalocaudal direction. The newborn should be examined in good daylight. The skin of forehead, chest, abdomen, thighs, legs, palms and soles should be blanched with digital pressure and the underlying color of skin and subcutaneous tissue should be noted. ● Yellow staining of palms and soles is a danger sign and requires urgent serum bilirubin estimation and further management. Non invasively,bilirubin levels can be assessed by transcutaneous bilirubinometer
  • 14. Serum levels of total bilirubin are approximately 4-6 mg/dL (zone 1), 6-8 mg/dL (zone 2) 8-12 mg/dL (zone 3) 12-14 mg/dL (zone 4) 15 mg/dL (zone 5) Yellow staining of palms and soles is a DANGER SIGN
  • 17. ● Lethargy ● Poor sucking ● Poor or absent Moro's ● Retrocollis-opisthotonos ● Convulsions Clinical Features of Acute Encephalopathy
  • 18. Clinical Features of Chronic Encephalopathy ● Athetosis ● Upward gaze ● Sensorineural hearing loss ● Dental enamel hypoplasia
  • 20.
  • 21.
  • 22. INVESTIGATIONS FIRST LINE • Total serum bilirubin and its fractions • Blood groups of mother and baby • Peripheral smear SECOND LINE • Hematocrit • G6PD levels • Sepsis screen • TFT • Urine for reducing substances • Specific enzyme
  • 24. ● Phototherapy is an effective and safe method for reducing indirect bilirubin levels, particularly when initiated before serum bilirubin increases to levels associated with kernicterus. ● In term infants - indirect bilirubin levels between 16 and 18 mg/dL. ● premature infants - bilirubin is at lower levels, to prevent bilirubin from reaching the high concentrations necessitating exchange transfusion. ● Blue lights and white lights are effective
  • 25. PRINCIPLES 1.Configurational isomerization :- Z isomers of bilirubin are converted to E isomers.The reaction is instantaneous upon exposure to light but reversible as bilirubin reaches the bile duct. 2.Structural Isomerization:- Irrevrsible reaction where bilirubin is converted into lumirubin.The reaction is directly proportional to dose of phototherapy.responsible for the main decline in TSB
  • 26. TYPES OF PHOTOTHERAPY LIGHTS ● Compact flouroscent lamps ● Halogen bulbs ● High intensity LED ● Fibreoptic light source With easy availability and low cost in Inida,CFL phototherapy is being most commonly used device.Often CFL devices
  • 27. Side effects of phototherapy ● Increased insensible water loss ● Loose stools ● Skin rash ● Bronze baby syndrome ● Hypertherma ● May result in hypocalcemia
  • 29. ● Exchange transfusion usually is reserved for infants with dangerously high indirect bilirubin level who are at risk for kernicterus. ● The exchangeable level of indirect bilirubin for other infants may be estimated by calculating 10% of birth weight in grams
  • 30. STEPS ● Normal blood volume in neonates – 80 ml/kg in a full term baby. ● Therefore 160 ml/kg of blood is required for exchange transfusion (after blood grouping and cross matching ). ● Procedure has to be performed under complete aseptic precautions. ● Baby placed in supine position. ● Perform Umbilical vein catheterization and confirm position by radiograph. ● If isovolumetric double exchange is to be done umbilical artery catheter is to be inserted. ● Have the unit of blood ready.Attach the bag of blood to the tubings and confirm orientation of 3 way stopcocks.
  • 31. ● Establish the volume of each aliquot ● Exchange transfusion is done by the push pull technique through the umbilical vein ● After exchange transfusion,phototherapy is continued and bilirubin lebels are measured every 12 hours. ● Complications – metabolic acidosis, electrolyte abnormalities, hypoglycemia, hypocalcemia, thrombocytopenia, volume overload, arrythmia, infection, GVHD and death
  • 32.
  • 33. 3.Intravenous immune globulin ● IVIG in infants with Rh or ABO isoimmunization can significantly reduce the need for exchange transfusions. ● Now IVIG has replaced exchange transfusion as the second-line treatment in infants with isoimmune jaundice. ● IVIG 0.5-1 gm/kg/dose IV repeat 12 hourly
  • 34. 4.Phenobarbital (Luminal) Hyperbilirubinemia: 3-8 mg/kg/d PO/IV initially; may increase up to 12 mg/kg/d Not to exceed IV administration rate of 1 mg/kg/min or 30 mg/min for infants.It increases the hepatic glucuronly transferase activity – criggler najar syndrome,gilbert syndrome